(+/-)-(3-((1R,2R,4S)-7-azabicyclo[2.2.1]heptan-2-yl)phenyl)methanol

ID: ALA3758513

Chembl Id: CHEMBL3758513

PubChem CID: 127027054

Max Phase: Preclinical

Molecular Formula: C13H17NO

Molecular Weight: 203.28

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OCc1cccc([C@H]2C[C@@H]3CC[C@H]2N3)c1

Standard InChI:  InChI=1S/C13H17NO/c15-8-9-2-1-3-10(6-9)12-7-11-4-5-13(12)14-11/h1-3,6,11-15H,4-5,7-8H2/t11-,12+,13+/m0/s1

Standard InChI Key:  XNXRWSAXXLYNOY-YNEHKIRRSA-N

Alternative Forms

  1. Parent:

    ALA3758513

    ---

Associated Targets(Human)

CHRNB4 Tclin Neuronal acetylcholine receptor; alpha3/beta4 (2283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna7 Neuronal acetylcholine receptor protein alpha-7 subunit (3047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 203.28Molecular Weight (Monoisotopic): 203.1310AlogP: 1.79#Rotatable Bonds: 2
Polar Surface Area: 32.26Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.72CX LogP: 1.47CX LogD: -1.51
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.77Np Likeness Score: 1.63

References

1. Matera C, Quadri M, Sciaccaluga M, Pomè DY, Fasoli F, De Amici M, Fucile S, Gotti C, Dallanoce C, Grazioso G..  (2016)  Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.,  108  [PMID:26706350] [10.1016/j.ejmech.2015.11.045]

Source